Consequences of Organ Transplant in Donors and Recipients

Soumi Saha *

Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, India.

Shashank Banait

Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, India.

*Author to whom correspondence should be addressed.


Abstract

Organ Transplant has developed marvelously at a rapid pace and has become a major lifeguard. It has increased the survival rate of patients but certain complications are worth not ignorance .They should be treated as soon as possible for betterment of lifestyle, which otherwise may land up in life threatening conditions. A combined multiorgan transplant may offer a lower rate of graft rejection and lesser dependence on immunosuppressants. After transplant course can be followed by a few complications that can be early, late, and severe. Nevertheless, keeping a watch , regular follow ups and managing can determine the post operative cause of graft rejection. However, there has been a major increase in the demand for potential organs which is unable to met with the limited supply of donors. This hassle has left more patients in the country helpless. The shortage of existing organ crisis has deprived a lot of people from leading a better life and that gave rise to life time dependence on costly medical procedures like dialysis. Implementation of certain procedures of awareness and educational approach to people, about donating more organs on their consent, rewarding a gift of life to the people in need. This review has jotted down a few complications , that can arise post operative from the donor and recipient point of view, alongside the benefits associated with it . There’s no doubt Organ Transplant is a boon and a curse, but it has increased the life style of patients, family and friends.

Keywords: Organ transplant, benefits, drawbacks, physical, psychological, social, metabolic


How to Cite

Saha, S. and Banait, S. (2021) “Consequences of Organ Transplant in Donors and Recipients”, Journal of Pharmaceutical Research International, 33(61A), pp. 115–121. doi: 10.9734/jpri/2021/v33i61A35123.